YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancem...

por Lam, Wing, Arammash, Mohammad, Cai, Wei, Guan, Fulan, Jiang, Zaoli, Liu, Shwu-Huey, Cheng, Peikwen, Cheng, Yung-Chi
Publicado 2023